DMS/NIGMS 1: Developing a mathematical framework to understand viral-cellular transduction — NSF Award to North Carolina State Uni
Genetically engineered cell therapies are transforming how doctors treat challenging diseases like cancer, sickle cell disease, HIV, and autoimmune conditions. These treatments work by giving a patient’s own cells a new ability to find and fight disease more effectively. A crucial step in making these cell therapies ac
| Award title | DMS/NIGMS 1: Developing a mathematical framework to understand viral-cellular transduction |
|---|---|
| Award ID | 2451660 |
| Awardee | North Carolina State University |
| City | RALEIGH |
| State | NC |
| Amount obligated | $500,000 |
| Principal investigator | Andrey Kuznetsov |
| Program | NIGMS |
| Start date | 09/01/2025 |
| Abstract | Genetically engineered cell therapies are transforming how doctors treat challenging diseases like cancer, sickle cell disease, HIV, and autoimmune conditions. These treatments work by giving a patient’s own cells a new ability to find and fight disease more effectively. A crucial step in making these cell therapies accessible is by swiftly delivering new genetic material into cells using viral vectors in a liquid medium. Porous materials that guide the flow of cells and viruses dramatically imp |
| Source | NSF Awards |
$799/mo
Try NSFGrants →